Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8716262 Nucleoside phosphoramidates

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87162620

Patent Inventor Names

Jinfa Du0

Michael Joseph Sofia0

Dhanapalan Nagarathnam0

Peiyuan Wang0

Date of Patent

May 6, 2014

Patent Application Number

126457650

Date Filed

December 23, 2009

Patent Citations Received

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 11690860 Treatment of HCV infected patients with cirrhosis

‌

US Patent 11707480 Highly active compounds against COVID-19

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

Patent Primary Examiner

‌

Traviss C Mcintosh, III

Patent abstract

A nucleoside compound having activity against hepatitis C virus is disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8716262 Nucleoside phosphoramidates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API